Metabolic signature of eyelid basal cell carcinoma.
In conclusion, eyelid BCC has a signature change of cell metabolome. Metabolites in NAD metabolic pathways could potentially be biomarkers or therapeutic targets for eyelid BCC.
PMID: 32649951 [PubMed - as supplied by publisher]
Source: Experimental Eye Research - Category: Opthalmology Authors: Huang J, Schaefer J, Wang Y, Gioia L, Pei Y, Shi X, Waris S, Zhao C, Nguyen J, Du J Tags: Exp Eye Res Source Type: research
More News: Basal Cell Carcinoma | Blepharoplasty | Cancer & Oncology | Carcinoma | Opthalmology | Skin Cancer | Study | Vitamin B3